Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Equity Bottom-Up

<ul>
<li>Aptamer Group 0.95p £25.62m (APTA.L) The developer of next-generation synthetic binders for the life sciences industry reports a new TrueAmp Library Preparation Kit is using Aptamer's proprietary Optimer binders.</li>
<li>These are being used as an enabling technology for stability at room temperature, the specialised TrueAmp polymerase maximises coverage across typically hard-to-sequence regions of the genome - while maintaining high accuracy during DNA copying.</li>
<li>This product launch demonstrates the real-world value of the Optimer technology in enabling market-ready products.</li>
</ul>


Aptamer Group 0.95p £25.62m (APTA.L) The developer of next-generation synthetic binders for the life sciences industry reports a new TrueAmp Library Preparation Kit is using Aptamer's proprietary Optimer binders.
These are being used as an enabling technology for stability at room temperature, the specialised TrueAmp polymerase maximises coverage across typically hard-to-sequence regions of the genome - while maintaining high accuracy during DNA copying.
This product launch demonstrates the real-world value of the Optimer technology in enabling market-ready products.


Hybridan Small Cap Feast: 11 February 2026